Access the full text.
Sign up today, get DeepDyve free for 14 days.
T. Mariani, Jeremy Reed, S. Shapiro (2002)
Expression profiling of the developing mouse lung: insights into the establishment of the extracellular matrix.American journal of respiratory cell and molecular biology, 26 5
D. Warburton, M. Schwarz, D. Tefft, G. Flores‐Delgado, K. Anderson, W. Cardoso (2000)
The molecular basis of lung morphogenesisMechanisms of Development, 92
C. Guilbault, J. Sanctis, G. Wojewodka, Z. Saeed, C. Lachance, Thomas Skinner, R. Vilela, S. Kubow, L. Lands, M. Hajdůch, E. Matouk, D. Radzioch (2008)
Fenretinide corrects newly found ceramide deficiency in cystic fibrosis.American journal of respiratory cell and molecular biology, 38 1
J. Bridges, T. Weaver (2006)
Use of transgenic mice to study lung morphogenesis and function.ILAR journal, 47 1
H Hamai, F Keyserman, LM Quittell, TS Worgall (2009)
Defective CFTR increases synthesis and mass of sphingolipids that modulate membrane composition and lipid signalingJ Lipid Res, 50
G. Wojewodka, J. Sanctis, D. Radzioch (2010)
Ceramide in Cystic Fibrosis: A Potential New Target for Therapeutic InterventionJournal of Lipids, 2011
I. Petrache, V. Natarajan, Lijie Zhen, Terry Medler, Amy Richter, C. Cho, W. Hubbard, E. Berdyshev, R. Tuder (2005)
Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in miceNature Medicine, 11
Allison Bonner, W. Lemon, Ming You (2003)
Gene expression signatures identify novel regulatory pathways during murine lung development: implications for lung tumorigenesisJournal of Medical Genetics, 40
Y. Hannun, L. Obeid (2008)
Principles of bioactive lipid signalling: lessons from sphingolipidsNature Reviews Molecular Cell Biology, 9
W. Cardoso (2000)
Lung morphogenesis revisited: Old facts, current ideasDevelopmental Dynamics, 219
D. Sillence, H. Ritchie, T. Dibbayawan, D. Eteson, K. Brown (1993)
Fragilitas ossium (fro/fro) in the mouse: a model for a recessively inherited type of osteogenesis imperfecta.American journal of medical genetics, 45 2
Neutral sphingomyelinase 2 deficiency and lung anomalies 763
Z. Khavandgar, Christophe Poirier, C. Clarke, Jingjing Li, Ning Wang, M. McKee, Y. Hannun, M. Murshed (2011)
A cell-autonomous requirement for neutral sphingomyelinase 2 in bone mineralizationThe Journal of Cell Biology, 194
Z Khavandgar, C Poirier, CJ Clarke, J Li, N Wang, MD McKee, YA Hannun, M Murshed (2011)
A cell-autonomous role for neutral sphingomyelinase 2 in bone mineralizationJ Cell Biol, 194
Antoine Robbesom, Elly Versteeg, Jacques Veerkamp, J Krieken, H. Bulten, Hans Smits, L.N.A. Willems, Cees Herwaarden, P Dekhuijzen, T. Kuppevelt (2003)
Morphological Quantification of Emphysema in Small Human Lung Specimens: Comparison of Methods and Relation with Clinical DataModern Pathology, 16
S. Filosto, S. Castillo, Aaron Danielson, L. Franzi, E. Khan, N. Kenyon, J. Last, K. Pinkerton, R. Tuder, T. Goldkorn (2011)
Neutral sphingomyelinase 2: a novel target in cigarette smoke-induced apoptosis and lung injury.American journal of respiratory cell and molecular biology, 44 3
M. Muriel, J. Bonaventure, R. Stanescu, P. Maroteaux, J. Guénet, V. Stanescu (1991)
Morphological and biochemical studies of a mouse mutant (fro/fro) with bone fragility.Bone, 12 4
E. Berdyshev, I. Gorshkova, P. Usatyuk, Yutong Zhao, B. Saatian, W. Hubbard, V. Natarajan (2006)
De novo biosynthesis of dihydrosphingosine-1-phosphate by sphingosine kinase 1 in mammalian cells.Cellular signalling, 18 10
Michal Levy, E. Khan, M. Careaga, T. Goldkorn (2009)
Neutral sphingomyelinase 2 is activated by cigarette smoke to augment ceramide-induced apoptosis in lung cell death.American journal of physiology. Lung cellular and molecular physiology, 297 1
J. Torres, C. Casanova, V. Pinto-Plata, N. Varo, P. Restituto, E. Córdoba-Lanús, R. Baz-Dávila, A. Aguirre-Jaime, B. Celli (2011)
Gender Differences in Plasma Biomarker Levels in a Cohort of COPD Patients: A Pilot StudyPLoS ONE, 6
V. Teichgräber, M. Ulrich, N. Endlich, J. Riethmüller, B. Wilker, Cheyla Oliveira–Munding, A. Heeckeren, M. Barr, G. Kürthy, K. Schmid, M. Weller, B. Tümmler, F. Lang, H. Grassmé, G. Döring, E. Gulbins (2008)
Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosisNature Medicine, 14
C. Longo, D. Tyler, R. Mallampalli (1997)
Sphingomyelin metabolism is developmentally regulated in rat lung.American journal of respiratory cell and molecular biology, 16 5
J. Guénet, R. Stanescu, P. Maroteaux, V. Stanescu (1981)
Fragilitas ossium: a new autosomal recessive mutation in the mouse.The Journal of heredity, 72 6
C. Dimitropoulou, F. Drakopanagiotakis, Anuran Chatterjee, C. Snead, J. Catravas (2009)
Estrogen Replacement Therapy Prevents Airway Dysfunction in a Murine Model of Allergen-Induced AsthmaLung, 187
R. Göggel, S. Winoto-morbach, G. Vielhaber, Y. Imai, K. Lindner, L. Brade, H. Brade, S. Ehlers, Arthur Slutsky, S. Schütze, E. Gulbins, S. Uhlig (2004)
PAF-mediated pulmonary edema: a new role for acid sphingomyelinase and ceramideNature Medicine, 10
P. Camp, H. Coxson, R. Levy, S. Pillai, W. Anderson, J. Vestbo, S. Kennedy, E. Silverman, D. Lomas, P. Paré (2009)
Sex differences in emphysema and airway disease in smokers.Chest, 136 6
I. Aubin, C. Adams, S. Opsahl, D. Septier, C. Bishop, N. Augé, R. Salvayre, A. Nègre-Salvayre, M. Goldberg, J. Guénet, C. Poirier (2005)
A deletion in the gene encoding sphingomyelin phosphodiesterase 3 (Smpd3) results in osteogenesis and dentinogenesis imperfecta in the mouseNature Genetics, 37
C. Poirier, A. Yoshiki, K. Fujiwara, J. Guénet, M. Kusakabe (2002)
Hague (Hag). A new mouse hair mutation with an unstable semidominant allele.Genetics, 162 2
Hiroko Hamai, F. Keyserman, L. Quittell, T. Worgall (2009)
Defective CFTR increases synthesis and mass of sphingolipids that modulate membrane composition and lipid signaling Published, JLR Papers in Press, January 14, 2009.Journal of Lipid Research, 50
Neutral sphingomyelinase 2 (nSMase2) upregulation was recently demonstrated to serve as a molecular link between smoke inhalation and emphysematous changes in lungs. Here we report that nSMase2 deficit impairs lung development in mice. We have shown previously that fragilitas ossium (fro) mice carry a mutation in the Smpd3 gene, rendering nSMase2 catalytically inactive. Analysis of lung phenotype revealed that fro mice have abnormally enlarged alveoli and increased compliance of the respiratory system, similar to morphological and functional manifestations of emphysema. Analysis of sphingolipid content in fro lungs revealed a decreased level of C14:0 ceramide but no significant alterations in the levels of sphingosine or sphingosine-1-phosphate. Altogether, our data suggest that nSMase2 activity and ceramide level are critical for lung development and function. Based on our data, ceramide can no longer be viewed as a lipid solely detrimental to lung function.
Mammalian Genome – Springer Journals
Published: Sep 4, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.